1h
Hosted on MSNMultiple states pushing to ban or restrict mRNA vaccinesThe "Make America Healthy Again" commission is reviewing certain vaccines as some states push to restrict the use of COVID-19 ...
Deep Track, a Greenwich, Ct., investment management company that holds 13.5% of Dynavax's stock, pointed its finger at ...
US scientists have discovered an alarming syndrome linked to the most commonly used Covid jab in the UK as the number of ...
HOSPITALS in England have been hit by a storm of norovirus infections, with cases reaching a record high. As well as bouts of ...
In the dark days of the coronavirus pandemic, Moderna (NASDAQ: MRNA) was a ray of light in more ways than one. The healthcare company's innovative Spikevax was one of the go-to vaccines that sped to ...
Moderna (NASDAQ:MRNA – Get Free Report)‘s stock had its “sector perform” rating reaffirmed by stock analysts at Royal Bank of Canada in a research report issued on Tuesday,Benzinga reports. They ...
A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study published in the journal Nature.
A new report emerging from a significant study at Yale University has uncovered alarming findings related to the immune responses of some individuals following vaccinations. The study, led by renowned ...
Nanoparticle characterization is vital for mRNA vaccine efficacy, ensuring safety and regulatory compliance in the ...
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...
A second federal judge paused Trump's order against gender-affirming care for youth. ( AP) Johnson & Johnson aims to have a ...
EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results